Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.

[1]  K. Moore,et al.  Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer. , 2017, Gynecologic oncology.

[2]  A. Secord,et al.  Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. , 2017, Gynecologic oncology.

[3]  Susana Banerjee,et al.  Improving outcomes for older women with gynaecological malignancies. , 2016, Cancer treatment reviews.

[4]  Ignace Vergote,et al.  Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. , 2016, The New England journal of medicine.

[5]  F. Chauvin,et al.  Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials. , 2016, Gynecologic oncology.

[6]  G. Fleming,et al.  The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years , 2016, Front. Oncol..

[7]  M. Brady,et al.  Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience , 2010, Cancer.

[8]  A. Levine,et al.  Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations , 2007, Proceedings of the National Academy of Sciences.

[9]  S. Loibl,et al.  Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  M. Markman,et al.  Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer. , 2005, Gynecologic Oncology.

[11]  M. Extermann,et al.  Management of cancer in the older person: a practical approach. , 2000, The oncologist.

[12]  U. Matulonis,et al.  Niraparib in Recurrent Ovarian Cancer. , 2017, New England Journal of Medicine.

[13]  F. Chauvin,et al.  Prognostic Factors for Overall Survival in Elderly Patients With Advanced Ovarian Cancer Treated With Chemotherapy: Results of a Pooled Analysis of Three GINECO Phase II Trials , 2017 .

[14]  W. Tew,et al.  Treatment and trials: ovarian cancer in older women. , 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.